000 01916 a2200541 4500
005 20250517222246.0
264 0 _c20190501
008 201905s 0 0 eng d
022 _a1432-1084
024 7 _a10.1007/s00330-018-5454-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFroelich, Matthias F
245 0 0 _aCT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.
_h[electronic resource]
260 _bEuropean radiology
_cDec 2018
300 _a5284-5292 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aColorectal Neoplasms
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aGermany
_xepidemiology
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aSurvival Rate
_xtrends
650 0 4 _aTomography, X-Ray Computed
_xmethods
700 1 _aHeinemann, Volker
700 1 _aSommer, Wieland H
700 1 _aHolch, Julian W
700 1 _aSchoeppe, Franziska
700 1 _aHesse, Nina
700 1 _aBaumann, Alena B
700 1 _aKunz, Wolfgang G
700 1 _aReiser, Maximilian F
700 1 _aRicke, Jens
700 1 _aD'Anastasi, Melvin
700 1 _aStintzing, Sebastian
700 1 _aModest, Dominik P
700 1 _aKazmierczak, Philipp M
700 1 _aHofmann, Felix O
773 0 _tEuropean radiology
_gvol. 28
_gno. 12
_gp. 5284-5292
856 4 0 _uhttps://doi.org/10.1007/s00330-018-5454-7
_zAvailable from publisher's website
999 _c28510224
_d28510224